Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK adopts proposed global harmonised HbA1c measurement

This article was originally published in Clinica

Executive Summary

From today, the UK is measuring HbA1c long-term blood glucose levels in diabetics in millimoles per mol (mmol/mol), as well as by percentage. The move is in response to calls by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) for all countries to harmonise HbA1c measurement, and so help all laboratories, worldwide, to compare results. For the next two years, the UK will use both units; from May 31 2011, it will use only the mmol/mol measurement. Diabetes UK is supporting the initiative with a converter tool on its website (diabetes.org.uk/HbA1c).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT042517

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel